These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 30541727

  • 1. Auditory and Histopathological Effects of Topical Mercurochrome Treatment in Rats with Tympanic Membrane Perforation.
    Korkmaz S, Ceylan ME, Ceylan G, Dalgıç A, İnan S, Olgun L, Özüer MZ.
    J Int Adv Otol; 2019 Apr; 15(1):22-27. PubMed ID: 30541727
    [Abstract] [Full Text] [Related]

  • 2. The effect of topical Castellani solution on outer hair cell function of rats.
    Gültekin E, Yener M, Ozdemir I.
    Laryngoscope; 2010 Apr; 120(4):808-12. PubMed ID: 20213791
    [Abstract] [Full Text] [Related]

  • 3. Ototoxicity caused by topical administration of gentamicin versus tobramycin in rabbits.
    Oghan F, Apuhan T, Yılmaz F.
    Int J Pediatr Otorhinolaryngol; 2011 Jul; 75(7):915-8. PubMed ID: 21592592
    [Abstract] [Full Text] [Related]

  • 4. The Effect of Nystatin Solution on Otoacoustic Emissions in Rats.
    Vural A, Şahin Mİ, Aydın M, Gündoğdu R, Arlı T, Okuducu H, Dizdar D, Külahlı İ.
    J Int Adv Otol; 2017 Apr; 13(1):105-109. PubMed ID: 27819649
    [Abstract] [Full Text] [Related]

  • 5. The impact of topical and systemic enoxaparin sodium use on traumatic tympanic membrane perforation and myringosclerosis.
    Bilge A, Gunes A, Dagli M, Koybasioglu FF, Guvey A.
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3035-41. PubMed ID: 26796878
    [Abstract] [Full Text] [Related]

  • 6. Effects of topical oxiconazole and boric acid in alcohol solutions to rat inner ears.
    Özdemir S, Tuncer Ü, Tarkan Ö, Akar F, Sürmelioğlu Ö.
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1023-7. PubMed ID: 23482479
    [Abstract] [Full Text] [Related]

  • 7. Effects of ozone (O3) therapy on cisplatin-induced ototoxicity in rats.
    Koçak HE, Taşkın Ü, Aydın S, Oktay MF, Altınay S, Çelik DS, Yücebaş K, Altaş B.
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4153-4159. PubMed ID: 27221387
    [Abstract] [Full Text] [Related]

  • 8. Protective role of misoprostol in prevention of gentamicin ototoxicity.
    Dogan M, Polat H, Yasar M, Bayram A, Karatas D, Hira İ, Kale A, Senel F, Özcan İ.
    Int J Pediatr Otorhinolaryngol; 2017 May; 96():140-144. PubMed ID: 28390604
    [Abstract] [Full Text] [Related]

  • 9. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP, Nelson K, Davis T, Dorn PA, Neely ST.
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [Abstract] [Full Text] [Related]

  • 10. Ototoxic effect of topical ciclopirox as an antimycotic preparation.
    Baylancicek S, Serin GM, Ciprut A, Sari M, Akdaş F, Tutkun A.
    Otol Neurotol; 2008 Oct; 29(7):910-3. PubMed ID: 18698269
    [Abstract] [Full Text] [Related]

  • 11. ABR and DPOAE detection of cochlear damage by gentamicin.
    Shi Y, Martin WH.
    J Basic Clin Physiol Pharmacol; 1997 Oct; 8(3):141-55. PubMed ID: 9429983
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
    Kara M, Türkön H, Karaca T, Güçlü O, Uysal S, Türkyılmaz M, Demirtaş S, Dereköy FS.
    Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
    [Abstract] [Full Text] [Related]

  • 13. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS, Prieve BA.
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [Abstract] [Full Text] [Related]

  • 14. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G, Namysłowski G, Hajduk A, Polok A, Tomaszewska R, Misiołek M.
    Otolaryngol Pol; 2006 Oct; 60(3):415-20. PubMed ID: 16989457
    [Abstract] [Full Text] [Related]

  • 15. Topical dexamethasone and tympanic membrane perforation healing in otitis media: a short-term study.
    Antonelli PJ, Winterstein AG, Schultz GS.
    Otol Neurotol; 2010 Apr; 31(3):519-23. PubMed ID: 20010446
    [Abstract] [Full Text] [Related]

  • 16. Vestibular Hypofunction Secondary to Topical Use of Aminoglycosides in Ears with Perforated Tympanic Membrane.
    González-Aguado R, Veiga-Alonso A, Morales-Angulo C.
    Audiol Neurootol; 2024 Apr; 29(5):425-428. PubMed ID: 38588647
    [Abstract] [Full Text] [Related]

  • 17. Distortion product otoacoustic emission (2f1-f2) amplitude as a function of f2/f1 frequency ratio and primary tone level separation in human adults and neonates.
    Abdala C.
    J Acoust Soc Am; 1996 Dec; 100(6):3726-40. PubMed ID: 8969474
    [Abstract] [Full Text] [Related]

  • 18. Ototoxic effect of topical oxiconazole and terbinafine in rats.
    Aydın E, Taştan E, Aydoǧan F, Karaca G, Asım Şafak M.
    J Otolaryngol Head Neck Surg; 2012 Apr; 41(2):78-83. PubMed ID: 22569007
    [Abstract] [Full Text] [Related]

  • 19. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D.
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [Abstract] [Full Text] [Related]

  • 20. Ear canal pressure variations versus negative middle ear pressure: comparison using distortion product otoacoustic emission measurement in humans.
    Sun XM.
    Ear Hear; 2012 Dec; 33(1):69-78. PubMed ID: 21747284
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.